Debt to Book Value: Anteris (AVR)

Anteris Technologies Global (AVR) management is currently undergoing an operational restructuring phase while awaiting FDA verdicts on heart prosthetics. Meanwhile, geopolitical tensions and logistical disruptions are increasing the cost of procuring biomaterials. This chart, where the indicator is 0.01, visualizes the price action of the developer's shares. The business relies on creating minimally invasive systems for heart valve regeneration, which minimizes scientific risks and expands demand.

Anteris - AVR Debts to Book Capitalization (period 12/14/2024 - 10/28/2026)

Metric breakdowns and analytics for anteristech.com (AVR)

- price and consensus price forecast:

Price Chart Anteris Technologies|AVR - Fair Value Consensus

- market capitalization data:

Market Valuation AVR|AVR - Aggregate Business Value

- book capitalization data:

Book Value per Share Anteris Technologies Global|AVR - Book Capitalization|Market Value to Book Value Ratio anteristech.com|AVR - Total Business Assets

- debt and liquidity data:

Total Debt to Equity Ratio Anteris Technologies Global|AVR - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Anteris Technologies|AVR - Company Cumulative Debt|Debt to Book Capitalization Ratio AVR

Summary company analytics:AVR, Anteris Technologies Ltd

This ratio determines the proportion of debt obligations within the overall equity structure, measuring the degree of financial leverage and the issuer's solvency risk. By analyzing the value of borrowed capital relative to book capitalization, an investor assesses how effectively Anteris Technologies Global (AVR) finances the development of the innovative DurAVR valve, balancing debt load and equity to scale cardiac surgery technologies.

Competitors of Anteris Technologies Global